SCHEMBL7790161

SCHEMBL7790161

CC(CCNC(=O)OCc1ccccc1)CC(=O)NCCC(C=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SLC1A3 P43003 1/20 0.46
SLC1A1 P43005 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
HTT P42858 1/20 0.44
TGM2 P21980 1/20 0.43
KCNA5 P22460 1/20 0.42
MAPT P10636 1/20 0.42
CTSL P07711 1/20 0.41
CTSS P25774 1/20 0.41
CNR1 P21554 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6465218 0.89 LMNA (0.57) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL6181962 0.82 CTSS (0.50) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL6183204 0.81 CTSS (0.49) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL6183160 0.81 CTSS (0.49) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL8327496 0.80 HTT (0.59) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL7456077 0.80 CTSS (0.57) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL6183151 0.80 SLC1A3 (0.52) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL6181806 0.80 CTSS (0.57) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL7799710 0.79 SLC1A3 (0.42) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1
SCHEMBL8324281 0.78 LMNA (0.56) LMNASMN1; SMN2SLC1A3SLC1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1159260-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000055124-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed